Tom Engber
Chief Tech/Sci/R&D Officer at Disarm Therapeutics, Inc.
Profile
Tom Engber's current job(s) include being a Senior Director at Takeda America Holdings, Inc., an Advisor at Atlas Venture Advisors, Inc., and the SVP & Chief Scientific Officer at Disarm Therapeutics, Inc. Mr. Engber's former job(s) include being a Director at Pfizer Inc. from 2013 to 2014, and a Director at Biogen-Idec Pharmaceuticals, Inc. from 2007 to 2012.
Mr. Engber's education history includes completing undergraduate and doctorate degrees at the University of Pennsylvania.
Tom Engber active positions
Companies | Position | Start |
---|---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2017-12-31 |
Takeda America Holdings, Inc.
Takeda America Holdings, Inc. Financial ConglomeratesFinance Takeda America Holdings, Inc. is a wholly owned subsidary of Takeda Pharmaceutical Co. Ltd.. It handles cash management & investment activities of the Takeda within the North America Region. The company was founded in 1993 and is headquartered in New York, NY. | Private Equity Investor | 2014-04-30 |
Former positions of Tom Engber
Companies | Position | End |
---|---|---|
PFIZER, INC. | Director/Board Member | 2014-04-30 |
Biogen-Idec Pharmaceuticals, Inc.
Biogen-Idec Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Spectrum Pharmaceuticals, Inc., Biogen-Idec Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in Gaithersburg, MD. | Private Equity Investor | 2012-07-31 |
Training of Tom Engber
University of Pennsylvania | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PFIZER, INC. | Health Technology |
Private companies | 4 |
---|---|
Takeda America Holdings, Inc.
Takeda America Holdings, Inc. Financial ConglomeratesFinance Takeda America Holdings, Inc. is a wholly owned subsidary of Takeda Pharmaceutical Co. Ltd.. It handles cash management & investment activities of the Takeda within the North America Region. The company was founded in 1993 and is headquartered in New York, NY. | Finance |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Biogen-Idec Pharmaceuticals, Inc.
Biogen-Idec Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Spectrum Pharmaceuticals, Inc., Biogen-Idec Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in Gaithersburg, MD. | Health Technology |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Tom Engber